More on NEPH
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $4.05 |
|
|||
| Open | $4.12 | ||||
| 52 Wk High | $0.60 | ||||
| 52 Wk Low | $0.20 | ||||
| Day High | $4.40 | ||||
| Day Low | $4.08 | ||||
| P/E | N/A | ||||
| EPS | $-0.27 | ||||
| Volume | 12,118 | ||||
- Form 4 NEPHROS INC For: Aug 18 Filed by: Wexford GP LLC
- Benchmark Reiterates Speculative Buy Rating on Nephros (NEPH) Following Strong Q2 Results
- Form 4 NEPHROS INC For: Aug 12 Filed by: Amron Arthur H
- Form 10-Q NEPHROS INC For: Jun 30
- Nephros Announces Strong Financial Results for Quarter Ended June 30, 2026
- Form 8-K NEPHROS INC For: Aug 06
- Nephros Schedules Second Quarter 2026 Financial Results Conference Call
- Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET
- Northland Starts Nephros (NEPH) at Market Perform
- Nephros added to Russell Microcap Index after 2026 reconstitution
Entities mentioned with NEPH
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Dividend | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Maxim Group | View Related Stories »
- Show More...
